Gene · 4738
Papers3,078
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 3,078
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Inhibiting neddylation: A new strategy for tumor therapy. | J Pharm Anal | 2025 | 40496066 | PubTator, text mining | PubMed |
| CXXC5 is a ubiquitinated protein and is degraded by the ubiquitin-proteasome pathway. | Protein Sci | 2025 | 40371716 | PubTator, text mining | PubMed |
| Interaction networks of SIM-binding groove mutants reveal alternate modes of SUMO binding and profound impact on SUMO conjugation. | Sci Adv | 2025 | 40367183 | PubTator, text mining | PubMed |
| Overcoming fluorescence loss in mEOS-based AAA+ unfoldase reporters through covalent linkage. | Protein Expr Purif | 2025 | 40306474 | PubTator, text mining | PubMed |
| Curcumin modulates β-catenin stabilization via targeting proteasomal deubiquitinating enzyme USP14☆. | Pharmacol Res | 2025 | 40294856 | PubTator, text mining | PubMed |
| Deciphering the roles of neddylation modification in hepatocellular carcinoma: Molecular mechanisms and targeted therapeutics. | Genes Dis | 2025 | 40290125 | PubTator, text mining | PubMed |
| NEDDylation Regulates CD8+ T-cell Metabolism and Antitumor Immunity. | Cancer Immunol Res | 2025 | 40261130 | PubTator, text mining | PubMed |
| Neddylation and MASLD: From Pathophysiology to Therapy. | Liver Int | 2025 | 40215082 | PubTator, text mining | PubMed |
| Insights into non-proteinaceous ubiquitination. | Biochem Soc Trans | 2025 | 40181599 | PubTator, text mining | PubMed |
| NUB1 reduction promotes PCNA-mediated tumor growth by disturbing the PCNA polyubiquitination/NEDDylation in hepatocellular carcinoma cells. | Cell Death Dis | 2025 | 40164590 | PubTator, text mining | PubMed |
| Neddylation as a target in PIK3CA-mutated head and neck cancer. | Biochem Biophys Res Commun | 2025 | 40154000 | PubTator, text mining | PubMed |
| CUL1-neddylation contributes to K29-linked ubiquitination on p27 for autophagic degradation in sorafenib-resistant liver cancer. | Cell Biol Toxicol | 2025 | 40111576 | PubTator, text mining | PubMed |
| Pan-cancer analysis unveils the role and mechanisms of neddylation modifications in tumorigenesis. | Med Oncol | 2025 | 40106140 | PubTator, text mining | PubMed |
| Targeting NEDD8 in pediatric acute myeloid leukemia: an integrated bioinformatics and experimental approach. | Hematology | 2025 | 40103351 | PubTator, text mining | PubMed |
| Non-Invasive Assessment of Neurogenesis Dysfunction in Fetuses with Early-Onset Growth Restriction Using Fetal Neuronal Exosomes Isolating from Maternal Blood: A Pilot Study. | Int J Mol Sci | 2025 | 40003962 | PubTator, text mining | PubMed |
| Chemical approaches to explore ubiquitin-like proteins. | RSC Chem Biol | 2025 | 39950163 | PubTator, text mining | PubMed |
| Distinct NF-kB Regulation Favors a Synergic Action of Pevonedistat and Laduviglusib in B-Chronic Lymphocytic Leukemia Cells Ex Vivo. | Cancers (Basel) | 2025 | 39941899 | PubTator, text mining | PubMed |
| Neddylation of RhoA impairs its protein degradation and promotes renal interstitial fibrosis progression in diabetic nephropathy. | Acta Pharmacol Sin | 2025 | 39900822 | PubTator, text mining | PubMed |
| Blockade of neddylation through targeted inhibition of DCN1 alleviates renal fibrosis. | Clin Sci (Lond) | 2025 | 39866066 | PubTator, text mining | PubMed |
| A phase I study of MLN4924 and belinostat in relapsed/refractory acute myeloid leukemia or myelodysplastic syndrome. | Cancer Chemother Pharmacol | 2025 | 39821392 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4738/papers?page=6